Functional Technologies Corp.
TSX VENTURE : FEB

Functional Technologies Corp.

June 15, 2009 12:59 ET

Functional Technologies Corp. Reports Trades

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 15, 2009) - Functional Technologies Corp. (TSX VENTURE:FEB) reports that certain of its directors, officers and other shareholders have today arranged a sale of a total of 1,570,000 shares at a price of $0.40 per share through the facilities of the TSX Venture Exchange. The sale proceeds will be used to fund the sellers' purchase of units in the private placement reported in the company's news release issued on June 8, 2009.

About Functional Technologies Corp.

Functional Technologies is a functional foods and biological health products company that develops and commercializes advanced yeast products, and other novel biological products, for the food and the health care industries. The company is currently commercializing a platform yeast technology that substantially reduces the formation of ethyl carbamate (also known as urethane, which has been recently reclassified by the World Health Organization up to a Group 2A carcinogen - the same carcinogen class as lead, mercury, acrylamide and diesel exhaust), from wines and other widely consumed fermented beverages and foods. As part of its core focus of improving and enhancing the quality of the global food and beverage supply, Functional Technologies has recently expanded its yeast portfolio through the licensing of proprietary hydrogen sulfide (H2S) reducing technology from the University of California at Davis. H2S is one of the most common occurring sensory defects, and a widespread problem, in wine production. In addition Functional Technologies, through its wholly-owned subsidiary Phyterra Bio Inc., is developing a platform of proprietary biological products, for animal health, utilizing proprietary science in the field of micro-algae.

For further company information, please access our website at www.functionaltechcorp.com.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information